Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
RQ3013-VLP Potential treatment - pre-clinical evidence Experimental Vaccine Aug/17/2020 1 0
89C8-ACE2 Potential treatment - pre-clinical evidence Experimental Antiviral Aug/17/2020 1 0
Artesunate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/13/2020 1 0
1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide Potential treatment - theoretical effect Experimental Antiviral Aug/01/2020 1 0
VSV-eGFP-SARS-CoV-2 Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020 1 0
cnCoVP-4 Potential treatment - theoretical effect Experimental Antiviral Jul/09/2020 1 0
cnCoVP-3 Potential treatment - theoretical effect Experimental Antiviral Jul/09/2020 1 0
cnCoVP-7 Potential treatment - theoretical effect Experimental Antiviral Jul/09/2020 1 0
Excel (.xslx) CSV (.csv)